OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(17)
Publication Date
Release Date
2022
(2)
2021
(2)
2019
(2)
2016
(2)
2012
(2)
2025
(1)
2024
(1)
2020
(1)
2018
(1)
2017
(1)
2014
(1)
2010
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Pharmacodynamic Study of Miransertib in Individuals with Proteus Syndrome.
Not available
S-EPMC6407523
|
biostudies-literature
Cite
Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum.
Not available
S-EPMC4320693
|
biostudies-literature
Cite
Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum.
Not available
S-EPMC6752269
|
biostudies-literature
Cite
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
Not available
S-EPMC9579910
|
biostudies-literature
Cite
Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy.
Not available
S-EPMC5873857
|
biostudies-literature
Cite
Mass Spectrometry-Based Visualization of Molecules Associated with Human Habitats.
Not available
S-EPMC6326777
|
biostudies-literature
Cite
Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations.
Not available
S-EPMC2947617
|
biostudies-literature
Cite
Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis.
Not available
S-EPMC3575525
|
biostudies-literature
Cite
Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI.
Not available
S-EPMC7032996
|
biostudies-literature
Cite
Assessment of health conditions from patient electronic health record portals vs self-reported questionnaires: an analysis of the INSPIRE study.
Not available
S-EPMC12012333
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets